FDA Inspection 1141774 — WES Pharma Inc.
The FDA completed an inspection of WES Pharma Inc. on April 28, 2021 in Westminster, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 28, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Westminster, MD (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)